ABSTRACT
objetivo deste estudo foi avaliar os efeitos da administração oral diária de extrato etanólico de R.officinalis no desenvolvimento do Tumor Sólido de Ehrlich. Camundongos Swiss foram separados em três grupos A, B e C (n=6). Os animais do grupo A (controle) ingeriram solução salina durante todo o experimento. Os animais do grupo B, a partir do 1º dia, receberam diariamente, por gavagem, uma dose de 100 mg/kg do extrato etanólico de R.officinalis. Os animais do grupo C iniciaram, no 21º dia, a ingestão diária desse extrato. No 21º dia, todos os camundongos foram inoculados subcutaneamente no coxim plantar esquerdo com 2 x 106 células do Tumor de Ehrlich. No 42º dia, os animais foram sacrificados e suas patas foram removidas para análise histopatológica. Os resultados obtidos, através da mensuração da espessura das patas, mostraram que o grupo controle e os grupos que receberam o extrato, apresentaram o mesmo crescimento tumoral. Nas análises histopatológicas, não foram observadas diferenças na morfologia das células tumorais entre os grupos. A administração oral diária de 100 mg/kg de extrato etanólico de Rosmarinus officinalis não afetou o potencial proliferativo de tumor. Outras concentrações do extrato etanólico de Rosmarinus officinalis serão estudadas em experimentos futuros.(AU)
The aim of this study was to evaluate the effects of daily oral administration of ethanol extract of R.officinalis in the development of Ehrlich solid tumor. Swiss mice were divided into three groups A, B and C (n = 6). The animals of group A (control) received saline throughout the experiment. The animals of group B, from day 1, received daily by gavage, a dose of 100 mg/kg of R.officinalis ethanol extract. The animals of group C, on day 21, began the daily intake of this extract. At day 21, all mice were inoculated with 2 x 106 Ehrlich tumor cells in the left footpad. On day 42, the animals were sacrificed; their footpads were measured and removed for histopathological analysis. The results showed that the control group and the groups receiving the extract, before and after tumor inoculation, presented the same tumor growth. Furthermore, the histopathological analysis showed no differences in the morphology of tumor cells between groups. The daily oral administration of 100 mg/kg ethanol extract of Rosmarinus officinalis did not affect the proliferative potential of tumor. Other concentrations this ethanol extract times will be studied in future experiments.(AU)
Subject(s)
Animals , Female , Mice , Plant Extracts/therapeutic use , Carcinoma, Ehrlich Tumor/drug therapy , Rosmarinus , Phytotherapy , Plant Extracts/administration & dosage , Administration, Oral , Disease Models, AnimalABSTRACT
Ethanol extract and fractions obtained from aerial parts of Smilax campestris were examined in order to determine their phenolic composition, antioxidant capacity and antifungal activities. High-performance liquid chromatography coupled with DAD analysis indicated that quercetin and rutin were the main phenolic compounds present in butanol fraction and ethanol extract, respectively. The antioxidant activity assessed by the scavenging ability on 1,1-diphenyl-2-picrylhydrazyl radical was significantly more pronounced for the ethanol extract and butanol fraction than that of the commercial antioxidant 2,6-di-tert-butyl-4-methylphenol. The antifungal activity of extract and fractions was investigated by using microdilution method against five Candida and two Cryptococcus yeast strains. Ethanol extract and fractions exhibited antifungal activities against Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis, Candida tropicalis and Cryptococcus gattii. This work provides the knowledge of profile and content of flavonoids and their antioxidant and antifungal activities in the extract and fractions of aerial parts of S. campestris.
